No doubt, one of the major future challenges in oncology will be early diagnosis and individualized, tailored treatment of cancer patients. Tailored cancer care is integrated into the concept of cancer medicine with the aim to gain information about a patients gene and/or protein expression profile, or functional imaging modifications, in order to identify patients at risk. Yet, questions remain how and when this concept will be turned into clinical routine to change clinical management. We will address these questions to key speakers at the WIN symposium and to an audience encompassing physicians, scientists, cancer researchers, healthcare organizations, and patient advocates. We will also ask biotechnology providers and representatives of the pharmaceutical industry.Join us in Paris for the first open interactive WIN symposium. It will be exclusively dedicated to personalized cancer care, aiming at improved survival of cancer patients and thus a better life. Register now, and actively participate in the WIN symposium by directing your questions to the symposium speakers. Once registered, a password and detailed instructions on how toparticipate in the forum will be delivered to each attendee.
ASCO ENDORSEMENT As a nonprofit organization, ASCO is dedicated toachieving its charitable mission outlined by the organizations founders in 1964. ASCO strongly supports all types of cancer research, but inparticular, patient-oriented clinical research. Endorsement implies that ASCO has approved in an official capacity the educational program, and has participated in its development. This program has the American Society of Clinical Oncology-s approval for quality of educational content.
DISCLAIMER ASCO endorsement does not constitute medical advice. Healthcare providers should exercise their own independent medical judgment.
Organizing committee: Gilles Vassal, Vladimir Lazar, Isabelle Pelletier-Bressac, Jean Feunteun, Antoine Crouan, Michael Bia, Jacques Crespy, Eric Solary
Scientific committee:
Chairman: Leroy Hood, Institute for Systems Biology, Seatle, USA